DE69208934D1 - Aspirin-Tablette mit Puffermatrix - Google Patents

Aspirin-Tablette mit Puffermatrix

Info

Publication number
DE69208934D1
DE69208934D1 DE69208934T DE69208934T DE69208934D1 DE 69208934 D1 DE69208934 D1 DE 69208934D1 DE 69208934 T DE69208934 T DE 69208934T DE 69208934 T DE69208934 T DE 69208934T DE 69208934 D1 DE69208934 D1 DE 69208934D1
Authority
DE
Germany
Prior art keywords
tablet
aspirin tablet
aspirin
buffer matrix
matrix material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69208934T
Other languages
English (en)
Other versions
DE69208934T2 (de
Inventor
Cynthia M Blase
Garnet E Peck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of DE69208934D1 publication Critical patent/DE69208934D1/de
Publication of DE69208934T2 publication Critical patent/DE69208934T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69208934T 1991-05-20 1992-05-07 Aspirin-Tablette mit Puffermatrix Expired - Lifetime DE69208934T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70250491A 1991-05-20 1991-05-20

Publications (2)

Publication Number Publication Date
DE69208934D1 true DE69208934D1 (de) 1996-04-18
DE69208934T2 DE69208934T2 (de) 1996-07-25

Family

ID=24821482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69208934T Expired - Lifetime DE69208934T2 (de) 1991-05-20 1992-05-07 Aspirin-Tablette mit Puffermatrix

Country Status (11)

Country Link
US (1) US5576024A (de)
EP (1) EP0514711B1 (de)
JP (1) JP3150763B2 (de)
KR (1) KR100225017B1 (de)
AT (1) ATE135222T1 (de)
AU (1) AU636538B2 (de)
CA (1) CA2067975C (de)
DE (1) DE69208934T2 (de)
DK (1) DK0514711T3 (de)
ES (1) ES2084867T3 (de)
GR (1) GR3019826T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238697B1 (en) 1998-12-21 2001-05-29 Pharmalogix, Inc. Methods and formulations for making bupropion hydrochloride tablets using direct compression
US20020022058A1 (en) * 2000-07-08 2002-02-21 Lovercheck Dale R. Unit dose of material in system and method
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
LU85943A1 (fr) * 1985-06-12 1987-01-13 Galephar Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
US4869984A (en) * 1988-12-21 1989-09-26 Eastman Kodak Company Electrophotographic elements containing certain naphthoquinone derivatives as electron-transport agents
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith

Also Published As

Publication number Publication date
AU1639092A (en) 1992-12-10
KR920021136A (ko) 1992-12-18
ES2084867T3 (es) 1996-05-16
DK0514711T3 (da) 1996-08-12
EP0514711A1 (de) 1992-11-25
CA2067975A1 (en) 1992-11-21
DE69208934T2 (de) 1996-07-25
CA2067975C (en) 2003-01-14
AU636538B2 (en) 1993-04-29
JP3150763B2 (ja) 2001-03-26
US5576024A (en) 1996-11-19
KR100225017B1 (ko) 1999-10-15
EP0514711B1 (de) 1996-03-13
ATE135222T1 (de) 1996-03-15
JPH05170652A (ja) 1993-07-09
GR3019826T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
DE69112698D1 (de) Anzeigeeinrichtung von höher Qualität mit aktiver Matrix.
DE69221844D1 (de) LCD-Anzeige mit rückseitigem mikrotexturiertem Reflektor sowie Verfahren zu seiner Herstellung
DE69401325D1 (de) Superabsorbierendes Polymer mit verbesserten Absorbiereigenschaften und Absorption unter Druck
NO900990D0 (no) Systemer for lagring og utlevering av gass.
AU8676791A (en) Clip and osteosynthesis plate with dynamic compression and self-retention
TR199700845T1 (xx) Aerojel'lerin tar�mda kullan�lmas�.
IT9067586A0 (it) Miscela polimerica amidacea particolarmente per la produzione di film e simili e procedimento per la sua produzione.
DE69106154D1 (de) Verzögerte Freisetzung mit hoch- und niedrigviskoser HPMC.
GR3024244T3 (en) Transmucosal drug delivery device.
DE68929091D1 (de) Tafel mit aktiver Matrix
DE68912482D1 (de) Dünnfilm-Transistoren, ihre Verfahren zur Herstellung und Anzeigeeinrichtung, die mit solchen Transistoren hergestellt sind.
DE68915413D1 (de) Anzeigevorrichtung mit aktiver Matrix.
DE69113418D1 (de) Matrixanzeigevorrichtung mit einer Einschreibeinrichtung.
TW405728U (en) Active matrix electro-optical device and projector having it
DE69109321D1 (de) Anzeigevorrichtung mit aktiver Matrix.
DE69110531D1 (de) Aktiv-Matrix-Anzeigevorrichtung mit Dünnfilmtransistorstruktur.
DE68924247D1 (de) Anzeigevorrichtung mit aktiver Matrix.
DE69222659D1 (de) Reproduktionsmethode und Reproduktionsapparat mit verbesserter Anzeige
IL90278A0 (en) Tablet coated with polymeric film
DE69020173D1 (de) Aktives Matrix-Substrat und Anzeigevorrichtung mit dieser aktiven Matrix.
CA2065500A1 (en) Light-polarizing material based on quinaldic acid derivatives
DE69433614D1 (de) Anzeigevorrichtung mit aktiver matrix
IT8553578V0 (it) Sopporto a treppiede particolarmente per macchine cinematografiche da ripresa e simili
DE69208934D1 (de) Aspirin-Tablette mit Puffermatrix
CA2106312A1 (en) Percutaneous anaesthesia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 514711

Country of ref document: EP